Our teams had the privilege of participating in the 52nd Annual European Society for Blood and Marrow Transplantation (EBMT) Meeting. It was an incredible opportunity to connect with our peers in this space as we work to bring hope to patients with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Learn more about our work in SCD and TDT: https://lnkd.in/ebztA3xN #EBMT26
These moments to connect and exchange perspectives across the community are so valuable, and can lead to a meaningful difference for patients.